Boardroom Alpha
Boardroom Alpha
DCH · Additional Proxy Materials (DEFA14A) · Filed April 20, 2026

Dauch Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 20, 2026
Ticker
DCH
Accession
0000947871-26-000454
Boardroom Alpha · Filing insights

Dauch urges vote FOR the 9,000,000-share Plan Amendment after ISS opposition; post-exercise holding policy adopted.

Proxy advisor rec.
About Dauch Corp
Market cap
$1.6B
1Y TSR
+46.2%
3Y TSR
−7.0%
Board grade
C+
Sector
Consumer Cyclical
CEO
David C Dauch
Last annual meeting: Apr 30, 2026 · View full Dauch Corp profile →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No.)

Filed by the Registrant 

Filed by a Party other than the Registrant  

Check the appropriate box:

Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
þ Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12

 

DAUCH CORPORATION

(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

þ No fee required
Fee paid previously with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 
 

SUPPLEMENT TO PROXY STATEMENT DATED MARCH 19, 2026

FOR THE ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD ON APRIL 30, 2026

 

Dear fellow stockholders,

The additional materials provided herein supplement, and should be read in conjunction with, the information regarding Proposal 3 - Approval of the Amended and Restated 2018 Omnibus Incentive Plan contained in the definitive proxy statement (the “Proxy Statement”) of Dauch Corporation (“we,” “us,” “our” or the “Company”) filed with the Securities and Exchange Commission on March 19, 2026, regarding the annual meeting of stockholders to be held on April 30, 2026, at 8:00 a.m. EST (the “2026 Annual Meeting”). From and after the date of this supplement, any references to the Proxy Statement will be deemed to include the Proxy Statement as supplemented hereby. Capitalized terms used herein, unless otherwise defined, have the meanings set forth in the Proxy Statement.

As more specifically described in the Proxy Statement, we are seeking stockholder approval to amend the Amended and Restated 2018 Omnibus Incentive Plan (the “Plan”), to increase the number of shares available for issuance under the Plan by 9,000,000 shares (the “Plan Amendment”). The Plan Amendment was approved by the Board on February 4, 2026.

Institutional Shareholder Services (“ISS”) issued its Proxy Analysis & Benchmark Policy Voting Recommendations (the “ISS Report”) related to the 2026 Annual Meeting. In the ISS Report, ISS recommended that stockholders vote against the proposal to approve the Plan Amendment. The commentary below addresses certain key concerns outlined in the ISS Report and provides supplemental data to ensure our stockholders have an opportunity to vote their shares based on accurate, up-to-date information.

The Company has adopted a post-exercise holding requirement policy

Among the reasons provided by ISS for its negative voting recommendation was the determination by ISS that the Company did not have a post-exercise holding requirement. On April 13, 2026, the Compensation Committee of the Board of Directors of Dauch Corporation approved a post-exercise holding requirement policy that provides that any shares issued to a named executive officer pursuant to the exercise of a stock option or stock appreciation right (net of any shares withheld or used to cover exercise price and applicable tax withholding obligations) will be subject to a holding period requirement. Specifically, none of our named executive officers may sell, transfer, or otherwise dispose of any such shares (except for mere changes in form in which the named executive officer holds such shares) before the earliest of (i) the twelve (12) month anniversary of the exercise of such shares; (ii) a change in control of the Company; (iii) the date such person ceases to provide services to the Company due to their death or disability; or (iv) the date the person is no longer designated as a "named executive officer”.

The Board reiterates its recommendation that you vote “FOR” the approval of Proposal 3.

If you have already voted, you do not need to vote again unless you would like to change or revoke your prior vote on any proposal. If you would like to change or revoke your prior vote on any proposal, please refer to page 97 of the Proxy Statement for instructions on how to do so.

 

Sincerely,

 

 

/s/ Kristen M. Netschke

Acting General Counsel

 

 

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Dauch Corp (DCH)

Reference

Frequently asked questions

When did Dauch Corp file this DEFA14A?
Dauch Corp (DCH) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 20, 2026. The accession number assigned by EDGAR is 0000947871-26-000454.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Dauch urges vote FOR the 9,000,000-share Plan Amendment after ISS opposition; post-exercise holding policy adopted. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
What events did Boardroom Alpha flag in this filing?
BA's event-extraction layer identified this signal in the filing text: "Proxy advisor rec.". It appears above the filing body as a labeled pill.
Where can I find Dauch Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Dauch Corp has filed under CIK 1062231, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer